Supply Chain News
Lipocine and Pharmalink Partner to Supply and Distribution of Oral Testosterone Therapy in GCC
Lipocine Inc., a biopharmaceutical company specialising in oral drug delivery technologies, has entered into an exclusive supply and distribution agreement with Pharmalink to commercialise TLANDO, its oral testosterone replacement therapy, across the Gulf Cooperation Council (GCC) region. The agreement covers
11 October 2024